IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation
William W. Cruikshank(Boston University), P F Weller(Boston University), Arthur C. Theodore(Boston University), Gregg Fine(Genesys (United States)), Kaiser G. Lim, Jennifer Cook(Boston University)
Cited by 133
Related Papers
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
|Nature|2014|2.4k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Treatment of Unexplained Chronic Cough
|CHEST Journal|2015|360